LATS1/2 antibody

LATS1/2 antibody

To Order: garrett@bioworldantibodies.com

LATS1/2 Polyclonal Antibody
ES2704-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against LATS1/2 from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

LATS1/2 Polyclonal Antibody
ABP59096-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein

LATS1/2 Polyclonal Antibody
ABP59096-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein

LATS1/2 Polyclonal Antibody
ABP59096-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse, Rat. This LATS1/2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 antibody protein

LATS1/2 Polyclonal Antibody
ABP51705-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041

LATS1/2 Polyclonal Antibody
ABP51705-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041

LATS1/2 Polyclonal Antibody
ABP51705-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of LATS1/2 from Human, Mouse. This LATS1/2 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the non-phosphorylation site of T1079/1041

Anti-LATS1/2 Antibody
A01051 100ul
EUR 476.4
Description: Rabbit Polyclonal LATS1/2 Antibody. Validated in IHC and tested in Human.

Anti-LATS1/2 Antibody
A01051-1 100ul
EUR 476.4
Description: Rabbit Polyclonal Antibody for LATS1/2 Antibody (LATS1) detection.tested for WB in Human, Mouse.

Anti-LATS1/2 antibody
STJ93908 200 µl
EUR 236.4
Description: Rabbit polyclonal to LATS1/2.

Anti-LATS1/2 antibody
STJ99623 200 µl
EUR 236.4
Description: Rabbit polyclonal to LATS1/2.

LATS1 Antibody
AF7669 200ul
EUR 540

LATS1 Antibody
AF7670 200ul
EUR 540

LATS1 Antibody
AF7671 200ul
EUR 540

LATS1 Antibody
1-CSB-PA012769GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

LATS1 Antibody
1-CSB-PA012769LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF, IP; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:500, IP:1:200-1:2000

LATS1 Antibody
1-CSB-PA830665
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100

LATS1 antibody
70R-51351 100 ul
EUR 292.8
Description: Purified Polyclonal LATS1 antibody

LATS1 antibody
70R-5683 50 ug
EUR 560.4
Description: Rabbit polyclonal LATS1 antibody

LATS1 antibody
70R-18222 50 ul
EUR 522
Description: Rabbit polyclonal LATS1 antibody

LATS1 Antibody
36187-100ul 100ul
EUR 302.4

lats1 Antibody
ABD7517 100 ug
EUR 525.6

LATS1 Antibody
RQ4584 100ug
EUR 419

LATS1 Antibody
F50049-0.08ML 0.08 ml
EUR 165

LATS1 Antibody
F50049-0.4ML 0.4 ml
EUR 379

LATS1 / 2 (pS909 / 872) Antibody
abx216529-100ug 100 ug
EUR 526.8

lats1/2 Blocking Peptide
DF7517-BP 1mg
EUR 234

LATS1 / 2 Blocking Peptide
20-abx061790
  • EUR 309.60
  • EUR 460.80
  • 1 mg
  • 5 mg

Phospho-LATS1/2 (Ser909/Ser872) Antibody
AF8163 200ul
EUR 540

LATS1/2 (Phospho-Ser909/872) Antibody
12514-100ul 100ul
EUR 302.4

LATS1/2 (Phospho-Ser909/872) Antibody
12514-50ul 50ul
EUR 224.4

LATS1/2 (Phospho-Thr1079/1041) Antibody
11736-100ul 100ul
EUR 302.4

LATS1/2 (Phospho-Thr1079/1041) Antibody
11736-50ul 50ul
EUR 224.4

LATS1 / 2 (Phospho-Thr1079 / 1041) Antibody
20-abx012605
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

LATS1/2 (Phospho- Ser909/872) Antibody
ABF8163 100 ug
EUR 525.6

LATS1/LATS2 Antibody
1-CSB-PA003141
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000

LATS1/LATS2 Antibody
CSB-PA069135-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100

LATS1 Conjugated Antibody
C36187 100ul
EUR 476.4

anti- LATS1 antibody
FNab04708 100µg
EUR 606.3
Description: Antibody raised against LATS1

LATS1 / LATS2 Antibody
abx331369-100ul 100 ul
EUR 510

LATS1 / LATS2 Antibody
20-abx325262
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Anti-LATS1 antibody
PAab04708 100 ug
EUR 426

Anti-LATS1 antibody
STJ11100931 100 µl
EUR 471.6
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.

Anti-LATS1 antibody
STJ119966 100 µl
EUR 332.4
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.

LATS1/LATS2 Antibody
CSB-PA069135- each
EUR 402
Description: A polyclonal antibody against LATS1/LATS2. Recognizes LATS1/LATS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100

LATS1 siRNA
20-abx922294
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

LATS1 siRNA
20-abx922295
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody
ABP56962-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of LATS1/2 phospho Thr1079/1041) from Human, Mouse. This LATS1/2 phospho Thr1079/1041) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the phosphorylation site of T1079/1041

LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody
ABP56962-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of LATS1/2 phospho Thr1079/1041) from Human, Mouse. This LATS1/2 phospho Thr1079/1041) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the phosphorylation site of T1079/1041

LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody
ABP56962-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of LATS1/2 phospho Thr1079/1041) from Human, Mouse. This LATS1/2 phospho Thr1079/1041) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human LATS1/2 around the phosphorylation site of T1079/1041

LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody
ES7961-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against LATS1/2 (phospho Thr1079/1041) from Human/Mouse. This antibody is tested and validated for IHC, WB, ELISA

LATS1/2 (phospho Thr1079/1041) Polyclonal Antibody
ES7961-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against LATS1/2 (phospho Thr1079/1041) from Human/Mouse. This antibody is tested and validated for IHC, WB, ELISA

LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody
ABP59095-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein

LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody
ABP59095-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein

LATS1/2 (Phospho-Thr1079/1041) Polyclonal Antibody
ABP59095-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of LATS1/2 Phospho-Thr1079/1041) from Human, Mouse, Rat. This LATS1/2 Phospho-Thr1079/1041) antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human LATS1/2 (Phospho-Thr1079/1041) Antibody protein

Anti-Phospho-LATS1/2 (T1079/1041) antibody
STJ91207 200 µl
EUR 236.4
Description: Rabbit polyclonal to Phospho-LATS1/2 (T1079/1041).

Anti-Phospho-LATS1/2 (Thr1079/1041) antibody
STJ99599 200 µl
EUR 236.4
Description: Rabbit polyclonal to Phospho-LATS1/2 (Thr1079/1041).

SARS-CoV-2 Nucleocapsid Protein, Avi-His-tag
E80027
  • EUR 635.80
  • EUR 4087.60
  • 1 ml
  • 100 ul

Recombinant SARS-CoV-2 Spike Glycoprotein(S) (D614G), Partial
E80028
  • EUR 388.30
  • EUR 860.20
  • 20 ul
  • 100 ul

SARS-CoV-2 Spike S1 RBD Protein, Avi-His-tag
E80024
  • EUR 635.80
  • EUR 4995.10
  • 100 ul
  • 1 ml

SARS-CoV-2 Spike S1 RBD Protein, Mouse Fc-fusion
E80026
  • EUR 588.50
  • EUR 823.90
  • 20 ul
  • 50 ul

Phospho-LATS1 (Thr1079) Antibody
AF7169 200ul
EUR 540

Phospho-LATS1 (Ser909) Antibody
AF7170 200ul
EUR 540

Phospho-LATS1 (Tyr283) Antibody
AF7171 200ul
EUR 540

LATS1 Antibody, HRP conjugated
1-CSB-PA012769LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

LATS1 Antibody, FITC conjugated
1-CSB-PA012769LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

LATS1 Antibody, Biotin conjugated
1-CSB-PA012769LD01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LATS1. Recognizes LATS1 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

LATS1/LATS2 Polyclonal Antibody
30393-100ul 100ul
EUR 302.4

LATS1/LATS2 Polyclonal Antibody
30393-50ul 50ul
EUR 224.4

LATS1 (Phospho-Thr1079) Antibody
13032-100ul 100ul
EUR 302.4

LATS1 (Phospho-Thr1079) Antibody
13032-50ul 50ul
EUR 224.4

LATS1 (Phospho-Ser909) Antibody
13033-100ul 100ul
EUR 302.4

LATS1 (Phospho-Ser909) Antibody
13033-50ul 50ul
EUR 224.4

LATS1 (Phospho-Tyr283) Antibody
13034-100ul 100ul
EUR 302.4

LATS1 (Phospho-Tyr283) Antibody
13034-50ul 50ul
EUR 224.4

Phospho- LATS1 (Thr1079) Antibody
ABF3638 100 ug
EUR 525.6

Anti-LATS1/LATS2 antibody
STJ11100242 100 µl
EUR 332.4

SARS-CoV-2 Spike S1 (16-685) Protein, Avi-His-tag
E80021
  • EUR 635.80
  • EUR 4276.80
  • 100 ul
  • 1 ml

SARS-CoV-2 Spike S1 RBD (V367F) Protein, Avi-His-tag
E80023
  • EUR 635.80
  • EUR 3934.70
  • 100 ul
  • 1 ml

SARS-CoV-2 Spike S1 (13-665) Protein, Fc Fusion, Avi-tag
E80020
  • EUR 635.80
  • EUR 4276.80
  • 100 ul
  • 1 ml

SARS-CoV-2 Spike S1 (16-685) Protein, Fc Fusion, Avi-tag
E80022
  • EUR 635.80
  • EUR 4276.80
  • 100 ul
  • 1 ml

SARS-CoV-2 Spike S1 RBD Protein, Human Fc-Fusion, Avi-Tag
E80025
  • EUR 635.80
  • EUR 3934.70
  • 100 ul
  • 1 ml

LATS1/2 (Phospho-Thr1079/1041) Polyclonal Conjugated Antibody
C11736 100ul
EUR 476.4

LATS1/2 (Phospho-Ser909/872) Polyclonal Conjugated Antibody
C12514 100ul
EUR 476.4

LATS1 cloning plasmid
CSB-CL012769HU1-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the LATS1 gene.

LATS1 cloning plasmid
CSB-CL012769HU2-10ug 10ug
EUR 829.2
Description: A cloning plasmid for the LATS1 gene.

LATS1 Rabbit pAb
A7159-100ul 100 ul
EUR 460.8

LATS1 Rabbit pAb
A7159-200ul 200 ul Ask for price

LATS1 Rabbit pAb
A7159-20ul 20 ul Ask for price

LATS1 Rabbit pAb
A7159-50ul 50 ul
EUR 318

LATS1 Blocking Peptide
AF7669-BP 1mg
EUR 234

LATS1 Blocking Peptide
AF7670-BP 1mg
EUR 234

LATS1 Blocking Peptide
AF7671-BP 1mg
EUR 234

LATS1 Blocking Peptide
33R-4095 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LATS1 antibody, catalog no. 70R-5683

LATS1 Blocking Peptide
20-abx064226
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

LATS1 Rabbit pAb
A17992-100ul 100 ul
EUR 369.6

LATS1 Rabbit pAb
A17992-200ul 200 ul
EUR 550.8

LATS1 Rabbit pAb
A17992-20ul 20 ul
EUR 219.6

LATS1 Rabbit pAb
A17992-50ul 50 ul
EUR 267.6

Anti-LATS1 (3A7)
YF-MA16671 100 ug
EUR 435.6
Description: Mouse monoclonal to LATS1

LATS1, GST-Tag
79499 10 µg
EUR 410
Description: Human LATS1 protein with N terminal GST-Tag, GenBank Accession No. NM_004690, a.a 589-end, expressed in an Sf9 expression system. MW = 95 kDa.

Recombinant Transmembrane Protease Serine 2 Protein, Partial
E80016
  • EUR 470.80
  • EUR 753.50
  • EUR 1824.90
  • 20 ul
  • 100 ul
  • 500 ul

LATS1 (Phospho-Thr1079) Conjugated Antibody
C13032 100ul
EUR 476.4

LATS1 (Phospho-Ser909) Conjugated Antibody
C13033 100ul
EUR 476.4

LATS1 (Phospho-Tyr283) Conjugated Antibody
C13034 100ul
EUR 476.4

LATS1/LATS2 Polyclonal Conjugated Antibody
C30393 100ul
EUR 476.4

LATS1 / LATS2 (pT1079 / 1041) Antibody
abx332955-100ul 100 ul
EUR 560.4

LATS1 / LATS2 (pT1079 / 1041) Antibody
20-abx325183
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Antibody for Human LATS1 (pSer909)
SPC-1005D 0.1ml
EUR 424.8
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is unconjugated.

Antibody for Human LATS1 (pSer909)
SPC-1005D-A390 0.1ml
EUR 481.2
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 390.

Antibody for Human LATS1 (pSer909)
SPC-1005D-A488 0.1ml
EUR 480
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 488.

Antibody for Human LATS1 (pSer909)
SPC-1005D-A565 0.1ml
EUR 480
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 565.

Antibody for Human LATS1 (pSer909)
SPC-1005D-A594 0.1ml
EUR 480
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 594.

Antibody for Human LATS1 (pSer909)
SPC-1005D-A633 0.1ml
EUR 480
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 633.

Antibody for Human LATS1 (pSer909)
SPC-1005D-A655 0.1ml
EUR 480
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 655.

Antibody for Human LATS1 (pSer909)
SPC-1005D-A680 0.1ml
EUR 480
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 680.

Antibody for Human LATS1 (pSer909)
SPC-1005D-A700 0.1ml
EUR 480
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to ATTO 700.

Antibody for Human LATS1 (pSer909)
SPC-1005D-ALP 0.1ml
EUR 472.8
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Alkaline Phosphatase.

Antibody for Human LATS1 (pSer909)
SPC-1005D-APC 0.1ml
EUR 478.8
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to APC .

Antibody for Human LATS1 (pSer909)
SPC-1005D-APCCY7 0.1ml
EUR 565.2
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to APC/Cy7.

Antibody for Human LATS1 (pSer909)
SPC-1005D-BI 0.1ml
EUR 475.2
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Biotin.

Antibody for Human LATS1 (pSer909)
SPC-1005D-DY350 0.1ml
EUR 570
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 350.

Antibody for Human LATS1 (pSer909)
SPC-1005D-DY405 0.1ml
EUR 542.4
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 405.

Antibody for Human LATS1 (pSer909)
SPC-1005D-DY488 0.1ml
EUR 518.4
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 488.

Antibody for Human LATS1 (pSer909)
SPC-1005D-DY594 0.1ml
EUR 523.2
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 594.

Antibody for Human LATS1 (pSer909)
SPC-1005D-DY633 0.1ml
EUR 511.2
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Dylight 633.

Antibody for Human LATS1 (pSer909)
SPC-1005D-FITC 0.1ml
EUR 470.4
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to FITC.

Antibody for Human LATS1 (pSer909)
SPC-1005D-HRP 0.1ml
EUR 465.6
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to HRP.

Antibody for Human LATS1 (pSer909)
SPC-1005D-P594 0.1ml
EUR 488.4
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to PE/ATTO 594.

Antibody for Human LATS1 (pSer909)
SPC-1005D-PCP 0.1ml
EUR 478.8
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to PerCP.

Antibody for Human LATS1 (pSer909)
SPC-1005D-RPE 0.1ml
EUR 476.4
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to RPE .

Antibody for Human LATS1 (pSer909)
SPC-1005D-STR 0.1ml
EUR 477.6
Description: A polyclonal antibody for LATS1 (pSer909) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Ser909 of human LATS1 (AA906-912). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This LATS1 (pSer909) antibody is conjugated to Streptavidin.

Phospho-LATS1/2 (Ser909/872) Blocking Peptide
AF8163-BP 1mg
EUR 234

LATS1 sgRNA CRISPR Lentivector (Human) (Target 2)
K1198203 1.0 ug DNA
EUR 184.8

Lats1 sgRNA CRISPR Lentivector (Mouse) (Target 2)
K3825503 1.0 ug DNA
EUR 184.8

Human LATS1(Serine/threonine-protein kinase LATS1) ELISA Kit
EH9736 96T
EUR 681.12
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml

Mouse Serine/threonine- protein kinase LATS1, Lats1 ELISA KIT
ELI-42693m 96 Tests
EUR 1038

Human Serine/threonine- protein kinase LATS1, LATS1 ELISA KIT
ELI-36986h 96 Tests
EUR 988.8

Human LATS1 shRNA Plasmid
20-abx956022
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse LATS1 shRNA Plasmid
20-abx971282
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

LATS1/LATS2 Rabbit pAb
A18286-100ul 100 ul
EUR 369.6

LATS1/LATS2 Rabbit pAb
A18286-200ul 200 ul
EUR 550.8

LATS1/LATS2 Rabbit pAb
A18286-20ul 20 ul
EUR 219.6

LATS1/LATS2 Rabbit pAb
A18286-50ul 50 ul
EUR 267.6

LATS1 ELISA KIT|Human
EF010629 96 Tests
EUR 826.8

Phospho-LATS1/LATS2 (T1079/1041) Antibody
1-CSB-PA070231
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (T1079/1041). Recognizes Phospho-LATS1/LATS2 (T1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/20000

Phospho-LATS1/LATS2 (Thr1079/1041) Antibody
CSB-PA905508-100ul 100ul
EUR 434.4
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (Thr1079/1041). Recognizes Phospho-LATS1/LATS2 (Thr1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100

Phospho-LATS1/LATS2 (Thr1079/1041) Antibody
CSB-PA905508- each
EUR 402
Description: A polyclonal antibody against Phospho-LATS1/LATS2 (Thr1079/1041). Recognizes Phospho-LATS1/LATS2 (Thr1079/1041) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100

ACE2, His-Tag Protein
E80019
  • EUR 612.70
  • EUR 1437.70
  • 20 ul
  • 100 ul

Large Tumor Suppressor Kinase 1 (LATS1) Antibody
20-abx113445
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Large Tumor Suppressor Kinase 1 (LATS1) Antibody
20-abx007804
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Large Tumor Suppressor Kinase 1 (LATS1) Antibody
abx033135-400ul 400 ul
EUR 627.6

Large Tumor Suppressor Kinase 1 (LATS1) Antibody
abx033135-80l 80 µl
EUR 343.2

Large Tumor Suppressor Kinase 1 (LATS1) Antibody
20-abx210537
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Large Tumor Suppressor Kinase 1 (LATS1) Antibody
20-abx312862
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Large Tumor Suppressor Kinase 1 (lats1) Antibody
abx216530-100ug 100 ug
EUR 526.8

Large Tumor Suppressor Kinase 1 (LATS1) Antibody
abx234708-100ug 100 ug
EUR 577.2

Anti-phospho-LATS1-S909/LATS2-S872 antibody
STJ11101017 50 µl
EUR 471.6
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.

Anti-phospho-LATS1-T1079/LATS2-T1041 antibody
STJ11101018 50 µl
EUR 471.6
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.

Anti-phospho-LATS1-S909/LATS2-S872 antibody
STJ11101039 100 µl
EUR 471.6
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.

Anti-phospho-LATS1-T1079/LATS2-T1041 antibody
STJ11101047 100 µl
EUR 471.6
Description: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.

Anti-Fascin 2/FSCN2 Antibody
A07840-2 100ug/vial
EUR 352.8

Anti-EIF4A1/2/3 Antibody
A03922-2 100ug/vial
EUR 400.8

Anti-Angiopoietin-2/ANGPT2 Antibody
A00370-2 100ug/vial
EUR 400.8

Anti-ErbB 2/ERBB2 Antibody
A00010-2 100ug/vial
EUR 400.8

Anti-Bcl-2/BCL2 Antibody
A00040-2 100ug/vial
EUR 400.8

Phospho-LATS1 (Thr1079) Blocking Peptide
AF7169-BP 1mg
EUR 234

Phospho-LATS1 (Ser909) Blocking Peptide
AF7170-BP 1mg
EUR 234

Phospho-LATS1 (Tyr283) Blocking Peptide
AF7171-BP 1mg
EUR 234

LATS1 ELISA Kit (Human) (OKEH07987)
OKEH07987 96 Wells
EUR 1075.2
Description: Description of target: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.078ng/mL

LATS1 ORF Vector (Human) (pORF)
ORF005858 1.0 ug DNA
EUR 114

LATS1 ORF Vector (Human) (pORF)
ORF005859 1.0 ug DNA
EUR 114

LATS1/2 antibody

Back To Top